The study's findings represent a major leap in understanding of multiple sclerosis and highlight the huge potential of glia as a target for therapeutic intervention, which may change the treatment prospects of many patients.

This article was published online on September 2 in the journal Nature cell biology by researchers at the University of Pompeii Fabra in Spain and ICREA Systems Bioengineering.

This world-first breakthrough could bring better personalized treatment to children with leukemia and bone marrow failure diseases.

The synthetic biology strategy developed in this study provides a promising solution to enhance the adhesion of xenogeneic cells and may help in the cultivation of human organs in animal models, thereby addressing the organ shortage crisis.

Recently, the University of Hong Kong School of Medicine collaborated with the University of Cambridge research team to create a new stem cell model that provides a personalized new treatment plan for patients with rare immunodeficiency disorders.

This study provides an important resource for basic research on delta cells and the development of diabetes treatment drugs

Studies have shown that CAP-exoASOs can achieve satisfactory results in the treatment of osteoarthritis and have huge development potential!

In this study, the Dux-H3K18la-MET regulatory network during iPSC reprogramming was demonstrated.